Skip to main content

Table 3 All Possible Treatment-Related Toxicity Eventsa (N = 12)

From: A prospective phase I dose-escalation trial of stereotactic ablative radiotherapy (SABR) as an alternative to cytoreductive nephrectomy for inoperable patients with metastatic renal cell carcinoma

Toxicity

Grade 1

Grade 2

Grade 3

Nausea

13

3

 

Vomiting

4

1

 

Altered Taste

4

  

Anorexia

 

1

 

Gas

 

2

 

Diarrhea

 

2

 

Constipation

1

  

Dermatitis

2

2

 

Fatigue

2

10

2

Pain - Abdominal

5

  

Pain - Bone

1

 

1

Weakness

2

1

 

Lower Limb Edema

4

  

Urinaryb

2

  

Insomnia

2

  

Neuropathy

1

  

Hot flashes

3

  

Dizziness

 

1

 

Headache

3

  
  1. aExpressed as no. of events using CTCAE v3.0 and including both acute (on treatment) and late (reported in follow-up ≥4 weeks post-SABR) bFrequency & urgency